Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Ophthalmol ; 101(1): 56-61, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27974321

ABSTRACT

AIMS: To quantify the changes of the choroidal structure in the enhanced depth imaging optical coherence tomographic (EDI-OCT) images after intravitreal aflibercept (IVA) injections for polypoidal choroidal vasculopathy (PCV). METHODS: Retrospective, observational case series. Forty eyes of 40 treatment-naive patients who underwent IVA for PCV were examined by EDI-OCT before, and 3 months and 12 months after IVA. The EDI-OCT images were binarised by ImageJ software. The cross-sectional luminal and stromal areas of the inner and outer subfoveal choroid of 1500 µm width were quantified. RESULTS: The stromal but not the luminal area of the inner choroid was significantly decreased at 3 months and 12 months after the IVA (stromal area, both p<0.001; luminal area, both p>0.050). On the other hand, the luminal but not the stromal area of the outer choroid was significantly decreased at 3 months and 12 months (luminal area, both p<0.001; stromal area, both p>0.050). The Pachychoroid Index, ratio of luminal/stromal area (L/S ratio) of the outer choroid divided by the L/S ratio of the inner choroid, was significantly decreased at 3 months and 12 months (both p<0.050). The Pachychoroid Index was increased and returned almost to the baseline level after recurrences and decreased again after successful re-treatment. The baseline Pachychoroid Index was significantly correlated with the presence of a dry macula, thinner fovea and better visual acuity at 12 months (all p<0.050). CONCLUSION: The binarisation of the EDI-OCT images can be used to quantify the activity of PCV and to predict the prognosis after IVA.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Choroid Diseases/drug therapy , Choroid/pathology , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Aged , Aged, 80 and over , Choroid Diseases/pathology , Cross-Sectional Studies , Female , Fluorescein Angiography , Humans , Intravitreal Injections , Male , Middle Aged , Retina/pathology , Retrospective Studies , Tomography, Optical Coherence , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...